Drug intelligence / Profile preview

valacyclovir + mecobalamin

Development stage
Unknown
Lead developer
Hangzhou First People's Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

valacyclovir + mecobalamin is a combination therapy used for the treatment of herpes zoster (shingles). Valacyclovir hydrochloride is an antiviral prodrug that is converted to acyclovir, which inhibits viral DNA polymerase, thereby blocking the replication of the Varicella-Zoster Virus (VZV). Mecobalamin, a coenzyme form of Vitamin B12, is utilized as a neuroprotective agent to promote nerve repair and alleviate neuropathic pain, such as postherpetic neuralgia, which is a common complication of herpes zoster. This specific combination is being evaluated by the First People's Hospital of Hangzhou in clinical studies to investigate its immunomodulatory effects and therapeutic outcomes when administered alongside electroacupuncture in patients with herpes zoster.

02

Targets

MTR (Methionine synthase)Herpesvirus DNA polymerase

Beyond the preview

Go deeper on valacyclovir + mecobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on valacyclovir + mecobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call